Industry Briefs: May 28, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Bend Research has expanded its existing hot-melt extrusion capacity with the addition of an 18-mm Leistritz twin-screw mixer/extruder.
Bristol-Myers Squibb formed the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientific understanding of immuno-oncology.
FEI has launched its
Mylan and Sunovion have entered into settlement agreements in the companies’ litigation relating to generic
Recipharm secures financing for a EUR 90-million ($112 million) loan facility for further acquisition of niche CDMOs, investment in existing facilities, and building long-term partnerships with major pharmaceuticals companies.
People News
Amgen has announced that Kevin W. Sharer has retired from his post as CEO and the company’s board of directors has appointed Robert A. Bradway his replacement.
DSM has appointed Laura Parks as president and business unit director of finished-dosage business.
Onyx Scientific has appointed Brian Jolly as its European business development director.
Pfizer has named Olivier Brandicourt as president and general manager of its emerging markets and established products business units.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
